copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Antimicrobial resistance Antimicrobial Resistance (AMR) occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections harder to treat and increasing the risk of disease spread, severe illness and death
General guidance on hold‑time studi 1 Introduction and background Manufacturers should ensure that the products that they manufacture are safe, efective and of the quality required for their intended use Systems should be in place to ensure that pharmaceutical products are produced according to validated processes and to defined procedures Manufacturing processes should be shown to be capable of consistently manufacturing
Anatomical Therapeutic Chemical (ATC) Classification In the Anatomical Therapeutic Chemical (ATC) classification system, the active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties Drugs are classified in groups at five different levels
World Health Organization (WHO) The United Nations agency working to promote health, keep the world safe and serve the vulnerable
Defined Daily Dose (DDD) - World Health Organization (WHO) Drug consumption can be expressed in cost, number of units, number of prescriptions or by the physical quantity of drugs However these variables can vary between regions and countries over time This limits comparisons of drug consumption at an international level To address this, a technical unit of measurement, the Defined Daily Dose (DDD) was created
WHO Drug Information About WHO Drug Information WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers Launched in 1987, WHO Drug Information communicates the latest international news and trends to regulatory agencies, academic and training institutions, researchers
Health products policy and standards Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain
WHO Model Lists of Essential Medicines The WHO Model Lists of Essential Medicines are updated every two years by the Expert Committee on Selection and Use of Essential Medicines The first Essential Medicines List was published in 1977, and the first Essential Medicines List for Children was published in 2007 The current versions, updated in September 2025, are the 24th Essential Medicines List (EML) and the 10th Essential
WHO updates list of drug-resistant bacteria most threatening to human . . . The World Health Organization (WHO) today released its updated Bacterial Priority Pathogens List (BPPL) 2024, featuring 15 families of antibiotic-resistant bacteria grouped into critical, high and medium categories for prioritization